BIOA (Bioage Labs) Stock Based Compensation: $14.04 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BIOA Bioage Labs Inc BIOA
12 GF Score
Price $10.49
! 3 Warning Signs
View Full Analysis

What is Bioage Labs Stock Based Compensation?

Bioage Labs BIOA -1.78% 12 Stock Based Compensation is $14.04 Mil as of Jun. 2026. GuruFocus rates BIOA with a GF Score™ of 12/100. The stock has 3 warning signs investors should review.

Bioage Labs's Stock Based Compensation for the three months ended in Jun. 2026 was $4.27 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 was $14.04 Mil.

Bioage Labs Stock Based Compensation Related Terms

Bioage Labs Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Bioage Labs's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioage Labs Stock Based Compensation Chart

Bioage Labs Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
2.54 3.02 6.98 11.69

Bioage Labs Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.23 2.79 2.72 4.26 4.27
BIOA
12GF Score
Bioage Labs Inc BIOA
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioage Labs Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $14.04 Mil.

What does a Stock Based Compensation of $14.04 Mil mean?
Bioage Labs (BIOA) has a Stock Based Compensation of $14.04 Mil as of Jun. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Bioage Labs and its competitors.
Is Bioage Labs' Stock Based Compensation too high?
Bioage Labs' current Stock Based Compensation is $14.04 Mil. Overall, Bioage Labs has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bioage Labs' Stock Based Compensation compare to PCRX and ALVO?
Bioage Labs' Stock Based Compensation of $14.04 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Drug Manufacturers company?
A good Stock Based Compensation depends on the Drug Manufacturers industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Bioage Labs and its competitors. Bioage Labs's current Stock Based Compensation is $14.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioage Labs stock overvalued right now?
Bioage Labs (BIOA) has a current Stock Based Compensation of $14.04 Mil. The current Stock Based Compensation is $14.04 Mil. Bioage Labs' overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Bioage Labs (BIOA), the current Stock Based Compensation is $14.04 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioage Labs Business Description

Other Exchanges Y7G:Germany
Address 1445A South 50th Street, Richmond, CA, USA, 94804
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
12GF Score

Get the complete analysis for BIOA

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.49
Price